Remove CalTech Remove Funding Remove Research Remove Venture Capital
article thumbnail

Capsida Uncloaks With $140M In Funding

socalTECH

Thousand Oaks-based Capsida Biotherapeutics, a new biotechnology company focused on using adeno-associated virus (AAV) engineering and cargo development platform to develop tissue-targeted gene therapies for multiple types of diseases, has uncloaked from stealth mode, saying it has raised $140M in total capital.

article thumbnail

Alta Devices, With Links to Caltech, Gains $72M

socalTECH

A new startup with links to Caltech has just raised $72M in funding. Alta Devices< is based on the research of Caltech's Harry Atwater, Professor of Applied Physics and Materials Science at Caltech, along with co-founder Eli Yablonovitch of UC Berkeley.

CalTech 164
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

SlipChip Gets $26.5M For Microfluidics Technology

socalTECH

Pasadena-based SlipChip , a Caltech spinoff developing microfluidics technology, has raised $26.5M as part of an ongoing, $30M funding raising effort, according to a filing from the company. Photo: Caltech, demonstration of technology licensed by SlipChip by the school. The filing says six investors participated in the round.

CalTech 100
article thumbnail

New Group Looks To Bridge Gap Between Research, Companies

socalTECH

Taking notice of the gap between the amount and depth of research and technology at local universities, and new company formation, a new group has quietly formed in Los Angeles to tackle the issue. The group includes a number of experienced CEOs with experience raising venture capital as well as bringing companies to an IPO or exit.

Research 164
article thumbnail

Southern California needs to find its hub for it to develop its own tech ecosystem

TechCrunch LA

We’ve also seen a substantial inflow of venture capital from all over the world.”. Our research revealed a saturation level causing unprecedented challenges, starting with exorbitant housing prices and runaway operating costs that accelerate a startup’s “burn rate”—its monthly spending.

article thumbnail

Indi Molecular Raises $1.5M For Antibody Startup

socalTECH

in a seed funding round. The funding was led by InterWest Partners, and also included a number of un-named angel investors. Caltech professor Jim Heath is a co-founder and board member of the startup, and the company has also licensed technology from the Scripps Research Institute. READ MORE>>.

article thumbnail

Indi Molecular Raises $11.5M

socalTECH

Culver City-based Indi Molecular , a developer of protein catalyzed capture agent (PCC) biotechnology being aimed in research tools, diagnostic agents, and PET imaging, has raised $11.5M in a Series A funding. Andreas Jurgeit from Merck Ventures and Dr. Darren Cai from Legend Capital will join the company's board with the funding.